Comerica Securities’s Twist Bioscience TWST Stock Holding History

Comerica Securities’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4	Closed	-$95	–	1343
2022 Q4	$95	Buy	+4	New	+$116	﹤0.01%	1506

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Comerica Securities's TWST Position: Q1 2023 in Review

Comerica Securities sold out of Twist Bioscience (TWST) in Q1 2023, closing a stake of 4 shares — an estimated $95 sold.

Comerica Securities first reported a position in TWST in Q4 2022 and held it in 1 quarter. The position peaked at $95 in Q4 2022. 201 funds tracked by Wall St. Rank hold TWST as of Q1 2023.

Comerica Securities reported no remaining Twist Bioscience position as of Q1 2023 after selling out during the quarter.
Comerica Securities sold 4 Twist Bioscience shares in Q1 2023, an estimated $95.
Comerica Securities first reported a position in Twist Bioscience in Q4 2022 and held it in 1 quarter.
Comerica Securities's Twist Bioscience position peaked at $95 in Q4 2022.
201 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2023.

Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.